ReviewLiver international : official journal of the International Association for the Study of the Liver2025

Focus on Semaglutide 2.4 mg/week for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis.

Salvatore Petta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.